Leading stocks in today’s market: Grifols, S.A. (NASDAQ:GRFS)

With its market value over its outstanding shares, Grifols, S.A. (NASDAQ:GRFS) Biotechnology has a market capitalization valued at Biotechnology. As the outstanding stock of Grifols, S.A. NASDAQ:GRFS Biotechnology is bought and sold in the stock market, the current market cap indicates the existing public opinion of the net worth of Grifols, S.A. GRFS Biotechnology. The existing figure surely determines the key factor in some forms of the stocks valuation. The present market cap reflects only on the equity of NASDAQ:GRFS Biotechnology and is vital to note that the firm’s choice of capital structure holds a substantial impact on how the aggregate value of the company allocated within the equity and debt.

Grifols, S.A. (NASDAQ:GRFS) Biotechnology has a Price Earning Ratio of 42.02, which in return shows a value of 16.1 on the Forward PE Ratio. The current PEG for Grifols, S.A. NASDAQ:GRFS is valued at 2.8 with a P/S value of 2.74.

Grifols, S.A. (NASDAQ:GRFS) Biotechnology prevailing Dividend Yield is 2.26% that has a Payout Ratio of *TBA. The firm has an EPS value of 0.41, resultantly displaying an EPS growth for this year at -4.00%. Grifols, S.A. GRFS measures an EPS growth for 2017 at a rate of 11.50% that consequently shows an EPS growth of 31.48% for the past five years, and an EPS growth of 15.00% for the following five years.

Return on Assets (ROA) for Grifols, S.A. NASDAQ:GRFS Biotechnology is currently valued at *TBA. Company’s Return on Investment (ROI) shows a figure of *TBA. The Current Ratio of Grifols, S.A. NASDAQ:GRFS Biotechnology is *TBA and the Quick Ratio measures to be *TBA. The Long Term Debt/Equity is valued *TBA with the Total Debt/Equity of *TBA.

Grifols, S.A. (NASDAQ:GRFS) Biotechnology exhibits an Operating Margin of *TBA and a Gross Margin of *TBA, therefore, displaying a Profit Margin of *TBA. The 20-Day Simple Moving Average is determined at 6.45% that showed a 200-Day Simple Moving Average of 8.68%.

The current Stock Price for Grifols, S.A. (NASDAQ:GRFS) Biotechnology is 17.2 with a change in price of -0.17%. Grifols, S.A. GRFS showed a Day High of -1.32% in today’s Market that also showed a Day Low of 20.03%. Its 52-Week High was -1.32% and 52-Week Low was 22.97%.

Disclaimer:  Outlined statistics and information communicated in the above editorial are merely a work of the authors. They do not ponder or echo the certified policy or position of any business stakeholders, financial specialists, or economic analysts. Specimens laid down on the editorial above are only cases with information collected from various sources. The authority will not be liable for anyone who makes stock portfolio or financial decisions as per the editorial, which is based only on limited and open source. 

Share This Post

Post Comment